Factors Predicting Preservation of Erectile Function in Men Undergoing Open Radical Retropubic Prostatectomy

Tracy Marien, Alexander I. Sankin, Herbert Lepor

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Purpose: The development of erectile dysfunction represents a major concern for potent men with localized prostate cancer undergoing open radical retropubic prostatectomy. We identified factors predicting the preservation of erectile function in men undergoing open radical retropubic prostatectomy. Materials and Methods: Between October 2000 and September 2005 a total of 1,110 men underwent open radical retropubic prostatectomy by a single surgeon. The UCLA-PCI was self-administered at baseline, and at 3, 6, 12 and 24 months postoperatively. The 728 (66%) men who responded that they engaged in sexual intercourse with or without taking phosphodiesterase type 5 inhibitors in the month before surgery and who were not dependent on intracavernous injections, intraurethral suppositories, vacuum devices or penile prostheses were considered potent. Followup was available for 659 men. Of the evaluable men 25 received salvage radiation therapy, adjuvant chemotherapy or hormonal therapy and were excluded from the study. Univariate and multivariate analyses using a logistic regression model were used to identify factors predicting the preservation of potency. Results: Age, coronary artery disease, diabetes mellitus, quality of preoperative erections, frequency of intercourse, hypertension, neurovascular bundle preservation and the use of phosphodiesterase type 5 inhibitors preoperatively predicted the preservation of potency. On multivariate analysis age, no history of diabetes mellitus and nerve sparing were independent predictors of the preservation of potency. Conclusions: We identified many factors that were predictors of the preservation of potency after open radical retropubic prostatectomy. Only age, no history of diabetes mellitus and neurovascular bundle preservation were independent predictors. These parameters should be considered when counseling surgical candidates so that erectile function expectations are realistic.

Original languageEnglish (US)
Pages (from-to)1817-1822
Number of pages6
JournalJournal of Urology
Volume181
Issue number4
DOIs
StatePublished - Apr 2009
Externally publishedYes

Fingerprint

Prostatectomy
Phosphodiesterase 5 Inhibitors
Diabetes Mellitus
Multivariate Analysis
Logistic Models
Penile Prosthesis
Salvage Therapy
Suppositories
Coitus
Erectile Dysfunction
Adjuvant Chemotherapy
Vacuum
Counseling
Coronary Artery Disease
Prostatic Neoplasms
Radiotherapy
Hypertension
Equipment and Supplies
Injections

Keywords

  • erectile dysfunction
  • prostate
  • prostatectomy
  • prostatic neoplasms
  • risk factors

ASJC Scopus subject areas

  • Urology

Cite this

Factors Predicting Preservation of Erectile Function in Men Undergoing Open Radical Retropubic Prostatectomy. / Marien, Tracy; Sankin, Alexander I.; Lepor, Herbert.

In: Journal of Urology, Vol. 181, No. 4, 04.2009, p. 1817-1822.

Research output: Contribution to journalArticle

@article{b798469858f04f839db68795d699a83c,
title = "Factors Predicting Preservation of Erectile Function in Men Undergoing Open Radical Retropubic Prostatectomy",
abstract = "Purpose: The development of erectile dysfunction represents a major concern for potent men with localized prostate cancer undergoing open radical retropubic prostatectomy. We identified factors predicting the preservation of erectile function in men undergoing open radical retropubic prostatectomy. Materials and Methods: Between October 2000 and September 2005 a total of 1,110 men underwent open radical retropubic prostatectomy by a single surgeon. The UCLA-PCI was self-administered at baseline, and at 3, 6, 12 and 24 months postoperatively. The 728 (66{\%}) men who responded that they engaged in sexual intercourse with or without taking phosphodiesterase type 5 inhibitors in the month before surgery and who were not dependent on intracavernous injections, intraurethral suppositories, vacuum devices or penile prostheses were considered potent. Followup was available for 659 men. Of the evaluable men 25 received salvage radiation therapy, adjuvant chemotherapy or hormonal therapy and were excluded from the study. Univariate and multivariate analyses using a logistic regression model were used to identify factors predicting the preservation of potency. Results: Age, coronary artery disease, diabetes mellitus, quality of preoperative erections, frequency of intercourse, hypertension, neurovascular bundle preservation and the use of phosphodiesterase type 5 inhibitors preoperatively predicted the preservation of potency. On multivariate analysis age, no history of diabetes mellitus and nerve sparing were independent predictors of the preservation of potency. Conclusions: We identified many factors that were predictors of the preservation of potency after open radical retropubic prostatectomy. Only age, no history of diabetes mellitus and neurovascular bundle preservation were independent predictors. These parameters should be considered when counseling surgical candidates so that erectile function expectations are realistic.",
keywords = "erectile dysfunction, prostate, prostatectomy, prostatic neoplasms, risk factors",
author = "Tracy Marien and Sankin, {Alexander I.} and Herbert Lepor",
year = "2009",
month = "4",
doi = "10.1016/j.juro.2008.11.105",
language = "English (US)",
volume = "181",
pages = "1817--1822",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Factors Predicting Preservation of Erectile Function in Men Undergoing Open Radical Retropubic Prostatectomy

AU - Marien, Tracy

AU - Sankin, Alexander I.

AU - Lepor, Herbert

PY - 2009/4

Y1 - 2009/4

N2 - Purpose: The development of erectile dysfunction represents a major concern for potent men with localized prostate cancer undergoing open radical retropubic prostatectomy. We identified factors predicting the preservation of erectile function in men undergoing open radical retropubic prostatectomy. Materials and Methods: Between October 2000 and September 2005 a total of 1,110 men underwent open radical retropubic prostatectomy by a single surgeon. The UCLA-PCI was self-administered at baseline, and at 3, 6, 12 and 24 months postoperatively. The 728 (66%) men who responded that they engaged in sexual intercourse with or without taking phosphodiesterase type 5 inhibitors in the month before surgery and who were not dependent on intracavernous injections, intraurethral suppositories, vacuum devices or penile prostheses were considered potent. Followup was available for 659 men. Of the evaluable men 25 received salvage radiation therapy, adjuvant chemotherapy or hormonal therapy and were excluded from the study. Univariate and multivariate analyses using a logistic regression model were used to identify factors predicting the preservation of potency. Results: Age, coronary artery disease, diabetes mellitus, quality of preoperative erections, frequency of intercourse, hypertension, neurovascular bundle preservation and the use of phosphodiesterase type 5 inhibitors preoperatively predicted the preservation of potency. On multivariate analysis age, no history of diabetes mellitus and nerve sparing were independent predictors of the preservation of potency. Conclusions: We identified many factors that were predictors of the preservation of potency after open radical retropubic prostatectomy. Only age, no history of diabetes mellitus and neurovascular bundle preservation were independent predictors. These parameters should be considered when counseling surgical candidates so that erectile function expectations are realistic.

AB - Purpose: The development of erectile dysfunction represents a major concern for potent men with localized prostate cancer undergoing open radical retropubic prostatectomy. We identified factors predicting the preservation of erectile function in men undergoing open radical retropubic prostatectomy. Materials and Methods: Between October 2000 and September 2005 a total of 1,110 men underwent open radical retropubic prostatectomy by a single surgeon. The UCLA-PCI was self-administered at baseline, and at 3, 6, 12 and 24 months postoperatively. The 728 (66%) men who responded that they engaged in sexual intercourse with or without taking phosphodiesterase type 5 inhibitors in the month before surgery and who were not dependent on intracavernous injections, intraurethral suppositories, vacuum devices or penile prostheses were considered potent. Followup was available for 659 men. Of the evaluable men 25 received salvage radiation therapy, adjuvant chemotherapy or hormonal therapy and were excluded from the study. Univariate and multivariate analyses using a logistic regression model were used to identify factors predicting the preservation of potency. Results: Age, coronary artery disease, diabetes mellitus, quality of preoperative erections, frequency of intercourse, hypertension, neurovascular bundle preservation and the use of phosphodiesterase type 5 inhibitors preoperatively predicted the preservation of potency. On multivariate analysis age, no history of diabetes mellitus and nerve sparing were independent predictors of the preservation of potency. Conclusions: We identified many factors that were predictors of the preservation of potency after open radical retropubic prostatectomy. Only age, no history of diabetes mellitus and neurovascular bundle preservation were independent predictors. These parameters should be considered when counseling surgical candidates so that erectile function expectations are realistic.

KW - erectile dysfunction

KW - prostate

KW - prostatectomy

KW - prostatic neoplasms

KW - risk factors

UR - http://www.scopus.com/inward/record.url?scp=62049084374&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62049084374&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2008.11.105

DO - 10.1016/j.juro.2008.11.105

M3 - Article

C2 - 19233413

AN - SCOPUS:62049084374

VL - 181

SP - 1817

EP - 1822

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 4

ER -